| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/13/2013 | US8506997 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/08/2013 | WO2013113074A1 Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/07/2013 | EP2623510A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 08/07/2013 | CN103232521A Tanshinone imidazole compound and its preparation method and use |
| 08/07/2013 | CN103232486A Vanadium oxide complex as well as preparation method and application thereof |
| 08/07/2013 | CN102319216B Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501691 Methods for treatment of headaches by administration of oxytocin |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | US8501264 Papaya puree and uses thereof |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | CA2751901C Mineralocorticoid receptor antagonist and methods of use |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013111729A1 Pharmaceutical composition and quasi-drug cosmetic using same |
| 08/01/2013 | WO2013110147A1 Computer -aided design of new alpha-amylase inhibitors |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 07/31/2013 | CN103223160A Cation complexes of insulin compund conjugates, formulation and uses thereof |
| 07/31/2013 | CN103223101A Traditional Chinese medicine for treating thyroid cyst |
| 07/31/2013 | CN102276627B Pyridino-heterocycle derivative |
| 07/31/2013 | CN101918427B 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/31/2013 | CN101910192B 19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives |
| 07/31/2013 | CN101910191B 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid gamma-lactone derivative, use thereof, and medicament containing said derivative |
| 07/31/2013 | CN101443017B Medication against breast cancer and related diseases |
| 07/30/2013 | CA2634006C Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine |
| 07/30/2013 | CA2540138C Recombinant antibody against human insulin-like growth factor |
| 07/30/2013 | CA2425174C Human gene critical to fertility |
| 07/25/2013 | WO2013109514A1 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor |
| 07/25/2013 | WO2013107743A1 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
| 07/25/2013 | WO2013081563A3 Stable voglibose tablet formulations |
| 07/24/2013 | EP2617465A1 Pharmaceutical and food compositions for preventing or treating diabetes or obesity |
| 07/24/2013 | EP2617464A1 Pharmaceutical and food compositions for preventing or treating diabetes or obesity |
| 07/24/2013 | EP2617411A1 Methods for the Treatment of Endometriosis |
| 07/24/2013 | EP2616070A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214471A Novel compound |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103212037A Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine |
| 07/24/2013 | CN103211977A Traditional Chinese medicine preparation used for treating hyperthyroidism |
| 07/24/2013 | CN103211773A Method for preparing leuprolide acetate microspheres |
| 07/24/2013 | CN103211769A Method of preparing a controlled release particle of soy isoflavone with biodegradable polymer using a supercritical fluid extraction of emulsion (SFEE) process |
| 07/24/2013 | CN103211750A Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (PCA) using a supercritical fluid |
| 07/24/2013 | CN102327368B Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 07/24/2013 | CN101827595B Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor |
| 07/24/2013 | CN101687902B 8-beta-substituted estratrienes as selectively active estrogens |
| 07/24/2013 | CN101669900B Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/23/2013 | US8492369 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| 07/23/2013 | US8492330 Formulation comprising GLP-1 |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | CA2607106C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/23/2013 | CA2544574C Stable vitamin b6 derivative |
| 07/18/2013 | WO2013105617A1 Use of disrupted product of chlorella cell wall for reducing serum resistin level |
| 07/18/2013 | WO2013104830A1 Novel heteroarylamide derivatives having antiandrogenic properties |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | CA2860968A1 Use of cell wall disrupted product of chlorella for reducing serum resistin level |
| 07/18/2013 | CA2860842A1 Methods of treating or preventing insulin resistance and associated diseases and conditions |
| 07/17/2013 | CN103209704A Organic Compounds |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103202965A Medicine for treating hyperthyroidism and preparation method thereof |
| 07/17/2013 | CN103202948A Medicinal liquor with kidney tonifying and hair blacking functions |
| 07/17/2013 | CN103202897A Agrimonia eupatoria active component for treating and improving insulin resistance, and application and extraction method thereof |
| 07/17/2013 | CN103202825A Application of curcumin analogue |
| 07/17/2013 | CN103202824A Application of pinitol to pharmacy and health care product |
| 07/17/2013 | CN102441109B Traditional Chinese medicinal composition for adjuvant treatment of hyperthyroidism |
| 07/17/2013 | CN102274267B Preparation method of vacuum packaged pseudostellaria roots |
| 07/16/2013 | US8486889 Composition and method for the treatment and prevention of endothelial dysfunction |
| 07/16/2013 | US8486455 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/16/2013 | US8486442 External patch containing estrogen and/or progestogen |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/11/2013 | WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders |
| 07/11/2013 | WO2013102665A1 Oromucosal liquid estradiol compositions |
| 07/11/2013 | CA2861141A1 Oromucosal liquid estradiol compositions |
| 07/10/2013 | CN103193860A Tanshinone compounds, preparation method and use thereof |
| 07/10/2013 | CN103191417A Long-effect blood-glucose-control medicine-controlled-release system loading insulin aggregate, and preparation method thereof |
| 07/10/2013 | CN103191416A Porcine insulin super-molecular aggregate and preparation method thereof |
| 07/10/2013 | CN103191306A Chinese medicinal external application medicament for treating thyroid nodules |
| 07/10/2013 | CN103191259A Pill for treating hypoadrenocorticism |
| 07/10/2013 | CN102070541B Letrozole I-type crystal and preparation method thereof |
| 07/10/2013 | CN101745005B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof |
| 07/10/2013 | CN101744998B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 07/09/2013 | US8481485 Insulin analogs |
| 07/09/2013 | CA2648936C Glp-1 compounds |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | US20130172300 New hormonal composition and its use |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/03/2013 | EP2609089A1 Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN102631623B Traditional Chinese medicine composite for treating thyroid associated ophthalmopathy and preparation method thereof |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |